
June 4, 2026
Why Not Mandatory GLP-1s In Medicare For Obesity? A Health Affairs Forefront Blog argues that GLP-1 coverage for obesity should be made mandatory. I have given great credit to the Trump administration for reducing drug prices, including with GLP-1s. But the proposed BALANCE reform model failed to attract enough health plans in the voluntary program. The government funding and risk mitigation just did not solve the fundamental risk problem, especially for standalone Part D (PDP) plans. Instead, Trump healthcare officials are proposing the BRIDGE program through 12/31/2027 to have the government cover the cost of such drugs for obesity. The authors argue that voluntary BALANCE failed to attract plans so other options exist: (Article may require a subscription.) #glp1s #weightlossdrugs #drugpricing #medicare #medicareadvantage #partd #pdp https://www.healthaffairs.org/content/forefront/after-balance-why-voluntary-coverage-obesity-drugs-failed-and-comes-next Commonwealth: One In Five Hit With Coverage Denials The Commonwealth Fund released its 2025 Affordability Survey, which found that one in five adults said
